Literature DB >> 15569236

Neonatal alloimmune thrombocytopenia due to an antibody against a labile component of human platelet antigen-3b (Bak b).

S Kataoka1, H Kobayashi, K Chiba, M Nakamura, S Shinada, S Morita, M Lin, Y Shibata.   

Abstract

We report the second case of neonatal alloimmune thrombocytopenia due to anti-human platelet antigen (HPA)-3b (Bak(b)) antibody. The infant was severely affected with intracranial haemorrhage. Most importantly, we were able to detect this antibody only by using fresh, unfixed platelets as antigen. This antibody was detectable neither by conventional mixed passive haemagglutination, platelet immunofluorescence test using fixed platelets, nor by monoclonal antigen immobilization of platelet antigen assay using solubilized platelets. We assume that this antibody reacts only with fresh platelets and that the antigen is a labile component of HPA-3b (Bak(b)).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569236     DOI: 10.1111/j.1365-3148.2004.00537.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  4 in total

1.  Bioengineered iPSC-derived megakaryocytes for the detection of platelet-specific patient alloantibodies.

Authors:  Nanyan Zhang; Sentot Santoso; Richard H Aster; Brian R Curtis; Peter J Newman
Journal:  Blood       Date:  2019-11-28       Impact factor: 22.113

2.  Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.

Authors:  Julie A Peterson; Stephanie M Balthazor; Brian R Curtis; Janice G McFarland; Richard H Aster
Journal:  Transfusion       Date:  2005-09       Impact factor: 3.157

3.  Platelet alloantibody detection: moving ahead.

Authors:  Adrian R Wilkie; Joseph E Italiano
Journal:  Blood       Date:  2019-11-28       Impact factor: 22.113

Review 4.  Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping.

Authors:  Tomoya Hayashi; Fumiya Hirayama
Journal:  Blood Transfus       Date:  2015-04-30       Impact factor: 3.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.